A realistic clinical perspective of tamoxifen and endometrial carcinogenesis
- 31 August 1996
- journal article
- review article
- Published by Elsevier BV in European Journal Of Cancer
- Vol. 32 (9), 1464-1476
- https://doi.org/10.1016/0959-8049(96)00184-0
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- DNA damage as assessed by 32P-postlabelling in three rat strains exposed to dietary tamoxifen: the relationship between cell proliferation and liver tumour formationCarcinogenesis: Integrative Cancer Research, 1995
- Gynecologic effects of tamoxifen and the association with endometrial carcinomaInternational Journal of Gynecology & Obstetrics, 1995
- Should clinicians be concerned about the carcinogenic potential of tamoxifen?European Journal Of Cancer, 1994
- Tamoxifen in Healthy Premenopausal and Postmenopausal Women: Different Risks and BenefitsJNCI Journal of the National Cancer Institute, 1994
- The Royal Marsden Hospital pilot tamoxifen chemoprevention trialBreast Cancer Research and Treatment, 1994
- Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 ratsBreast Cancer Research and Treatment, 1994
- Alternative mechanisms of action of anti-oestrogensBreast Cancer Research and Treatment, 1994
- Tamoxifen induces hepatocellular carcinoma in rat liver: A 1-year study with two antiestrogensArchives of Toxicology, 1993
- Endometrial lesions in patients undergoing tamoxifen therapyInternational Journal of Gynecology & Obstetrics, 1991
- Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancersPreventive Medicine, 1991